These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7230 related articles for article (PubMed ID: 22006764)

  • 1. Temozolomide-related infections: review of the literature.
    Kizilarslanoglu MC; Aksoy S; Yildirim NO; Ararat E; Sahin I; Altundag K
    J BUON; 2011; 16(3):547-50. PubMed ID: 22006764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.
    Su YB; Sohn S; Krown SE; Livingston PO; Wolchok JD; Quinn C; Williams L; Foster T; Sepkowitz KA; Chapman PB
    J Clin Oncol; 2004 Feb; 22(4):610-6. PubMed ID: 14726505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
    Meije Y; Lizasoain M; García-Reyne A; Martínez P; Rodríguez V; López-Medrano F; Juan RS; Lalueza A; Aguado JM
    Clin Infect Dis; 2010 Jun; 50(12):e73-6. PubMed ID: 20455691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma.
    Yaman E; Coskun U; Ozturk B; Buyukberber S; Kaya AO; Coskun O; Buyukberber N; Yildiz R; Benekli M
    J Clin Neurosci; 2009 Apr; 16(4):591-2. PubMed ID: 19201195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.
    Schwarzberg AB; Stover EH; Sengupta T; Michelini A; Vincitore M; Baden LR; Kulke MH
    Cancer Invest; 2007 Jun; 25(4):249-55. PubMed ID: 17612935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of temozolomide in the treatment of malignancies.
    Trinh VA; Patel SP; Hwu WJ
    Expert Opin Drug Saf; 2009 Jul; 8(4):493-9. PubMed ID: 19435405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide.
    Gorospe Sarasúa L; Ureña-Vacas A; Muñoz Del Toro JR
    Arch Bronconeumol; 2016 Oct; 52(10):534-5. PubMed ID: 27021139
    [No Abstract]   [Full Text] [Related]  

  • 9. Temozolomide for melanoma: new toxicities and new opportunities.
    Gajewski TF
    J Clin Oncol; 2004 Feb; 22(4):580-1. PubMed ID: 14726506
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids.
    Okita Y; Narita Y; Miyakita Y; Ohno M; Nagai S; Shibui S
    Intern Med; 2012; 51(20):2967-71. PubMed ID: 23064578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
    Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: a clinical audit.
    Gupta T; Mohanty S; Moiyadi A; Jalali R
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1814-9. PubMed ID: 23764039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in a patient on temozolomide: a case report.
    de Paiva TF; de Barros e Silva MJ; Rinck JA; Fanelli MF; Gimenes DL
    J Neurooncol; 2009 Mar; 92(1):33-5. PubMed ID: 18974931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme and hepatitis B: do the right thing(s).
    Purchiaroni F; Begini P; Minniti G; Gallina S; Delle Fave G; Marignani M
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3629-31. PubMed ID: 25535132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.
    Perry JR; Rizek P; Cashman R; Morrison M; Morrison T
    Cancer; 2008 Oct; 113(8):2152-7. PubMed ID: 18756530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
    Chou KN; Lin YC; Liu MY; Chang PY
    J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 362.